Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Phase II study of dasatinib in patients with advanced non-small-cell lung cancer.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Phase II study of dasatinib in patients with advanced non-small-cell lung cancer.
Phase II study of dasatinib in patients with advanced non-small-cell lung cancer. J Clin Oncol. 2010 Oct 20; 28(30):4609-15.
View in:
PubMed
subject areas
Aged
Antineoplastic Agents
Carcinoma, Non-Small-Cell Lung
Cytokines
Dasatinib
Disease-Free Survival
Enzyme Activation
ErbB Receptors
Female
Humans
Lung Neoplasms
Male
Middle Aged
Mutation
Phosphorylation
Positron-Emission Tomography
Protein Kinase Inhibitors
Proto-Oncogene Proteins
Proto-Oncogene Proteins p21(ras)
Pyrimidines
ras Proteins
src-Family Kinases
Texas
Thiazoles
Time Factors
Tomography, X-Ray Computed
Treatment Outcome
Tumor Burden
authors with profiles
Naoko Takebe